Synergy Pharmaceuticals Inc. is a privately held biopharmaceutical company that primarily develops human therapeutics based on iminosugars.
Assess how Synergy Pharmaceuticals, Inc.'s management team is paid from their Annual Proxy Screenshot example of actual Proxy Statement Synergy Pharmaceuticals, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
After more than a decade of development, US-based Synergy Pharmaceuticals Inc. (Synergy) received marketing approval from the US Federal
Synergy Pharmaceuticals. Corporate. Synergy Pharmaceuticals Inc. Announces Public Offering of Common Stock Corporate. Synergy
NEW YORK, J (GLOBE NEWSWIRE) - Synergy Pharmaceuticals Inc. (Nasdaq:SGYP) and Callisto Pharmaceuticals, Inc. (OTCBB:CLSP)
NASDAQ:SGYP Shareholder Notice: Deadline on Ap in Lawsuit Against Synergy Pharmaceuticals Inc San Diego, CA - (SBWIRE) - - The Shareholders Foundation announces that a deadline is coming up on Ap in the lawsuit filed for certain investors of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) over alleged securities laws violations by Synergy Pharmaceuticals Inc .
Synergy Pharmaceuticals Inc. recklessly mischaracterized to investors a financial arrangement his company was in.
After more than a decade of development, US-based Synergy Pharmaceuticals Inc (Synergy) received marketing approval from the US Federal Drug Administration
announced that the Company was selected as the successful bidder to acquire certain assets of Synergy Pharmaceuticals Inc. for a cash
Comments
5star story.